Directorate change

June 16, 2009 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that Rob Koremans has resigned in order to take up a senior position with a leading pharmaceutical company. He will leave the Group at the end of July at which time Marc Waeterschoot, the founder and former Chief Executive and currently Chairman, will become interim Chief Executive. Rob continues to be an advisor to the Group.

Marc Waeterschoot, Chairman of the Board, commented:

We are sorry that Rob is leaving us but clearly understand his reasons to take up this excellent opportunity. We wish him much success. However, he has built a strong and professional organisation and we have started our search for a new CEO, to pursue our current successful strategy.

 

We expect to publish our Q2 storage figures in early July. The Group continues to perform in line with our expectations.

 



For further details

Cryo-Save Group
+ 31 (0) 575 548998
Rob Koremans, Chief Executive
Arnoud van Tulder, Chief Financial Officer

Daniel Stewart & Company plc
+ 44 (0) 20 7776 6550
Simon Leathers/Charlotte Stranner

College Hill
+ 44 (0) 20 7457 2020
Adrian Duffield/Rozi Morris

 

About Cryo-Save

With more than 100,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction).

Cryo-Save sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases in the future. As a service to the public, Cryo-Save offers a Cost-free Family Donation Programme, free of charge, to families wishing to store their newborn’s umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treatable by stem cells. The company is committed to further improve stem cell cryopreservation techniques, by participating in European Commission funded projects, in Universities and Hospitals.

Related Articles